VHL and cancer: In conclusion, this work presents the possible mechanism by which the E6 and E7 oncoproteins of HPV 16 could be affecting the PHD2-VHL-CUL2-ELOC-HIF-1α backbone and, consequently, metabolic reprogramming in CC, HNSC, and CRC cancers.